PNC FINANCIAL SERVICES GROUP, INC. - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 2 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$22,000
+57.1%
247
+1.6%
0.00%
Q3 2021$14,000
+1300.0%
243
+2109.1%
0.00%
Q2 2021$1,0000.0%110.0%0.00%
Q1 2021$1,0000.0%110.0%0.00%
Q4 2020$1,0000.0%110.0%0.00%
Q3 2020$1,000
-75.0%
11
-82.5%
0.00%
Q2 2020$4,000
+33.3%
63
-3.1%
0.00%
Q1 2020$3,000
-76.9%
65
-79.6%
0.00%
Q4 2019$13,000
-99.1%
318
-99.0%
0.00%
-100.0%
Q3 2019$1,523,000
+50666.7%
33,257
+41997.5%
0.00%
Q1 2019$3,000
+50.0%
79
+58.0%
0.00%
Q4 2018$2,0000.0%50
-5.7%
0.00%
Q3 2018$2,000
-80.0%
53
-76.7%
0.00%
Q2 2018$10,000
-97.5%
227
-97.7%
0.00%
Q1 2018$393,000
+4.5%
9,956
-10.0%
0.00%
Q4 2017$376,000
-41.0%
11,060
-55.7%
0.00%
-100.0%
Q3 2017$637,000
+15825.0%
24,944
+12372.0%
0.00%
Q2 2017$4,0002000.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Prosight Management, LP 164,300$9,633,0004.86%
Atika Capital Management LLC 230,000$13,485,0002.65%
DAFNA Capital Management LLC 93,942$5,508,0002.07%
PFM Health Sciences, LP 1,828,378$107,198,0002.04%
Perceptive Advisors 1,380,171$80,919,0001.86%
Eversept Partners, LP 73,501$4,309,3641.21%
Partner Investment Management, L.P. 18,159$1,065,0001.13%
Rhenman & Partners Asset Management AB 170,000$9,967,0001.10%
EMERALD ADVISERS, LLC 425,510$24,948,0001.00%
EMERALD MUTUAL FUND ADVISERS TRUST 388,418$22,773,0000.90%
View complete list of ARENA PHARMACEUTICALS INC shareholders